Launch sugarBEAT continuous glucose monitor in territories outside the USA
Deadline passed; outcome being checked
- Announced
- 5 Mar 2021
- Due
- 31 Dec 2021
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“KEY MILESTONES FOR 2021 3. Launch sugarBEAT real time non - invasive continuous glucose monitor in a number of territories outside the USA”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- sugarBEAT continuous glucose monitor launch outside USA
- Where
- territories outside the USA
- In the company’s control
- Medium
- Specificity
- Medium
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Nemaura Medical Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C602078-025223 · Corrections policy